<DOC>
	<DOCNO>NCT02118792</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy AN2728 Topical Ointment , 2 % child , adolescent , adult ( age 2 year old ) atopic dermatitis .</brief_summary>
	<brief_title>Safety Efficacy AN2728 Topical Ointment , 2 % Children , Adolescents , Adults ( Aged 2 Years Older ) With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Males females 2 year old Has clinical diagnosis Atopic Dermatitis ( AD ) accord criterion Hanifin Rajka Has AD involvement â‰¥ 5 % Treatable % BSA ( exclude scalp ) Has ISGA score Mild ( 2 ) Moderate ( 3 ) Baseline/Day 1 All female subject childbearing potential must use acceptable method contraception Screening Visit continuously 30 day stop study drug As determine study doctor , medical history may interfere study objective Unstable AD consistent requirement high potency topical corticosteroid History use biologic therapy ( include intravenous immunoglobulin ) Recent anticipate concomitant use systemic topical therapy might alter course AD Recent current participation another research study Females breastfeeding , pregnant , plan get pregnant participation study Participation previous AN2728 clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>atopic dermatitis</keyword>
</DOC>